Ask about this stack
Get a grounded answer across clinical evidence, community patterns, and risks.
25
authors mention this stack
6
ran the components concurrently
MOTS-c + NAD+ + SS-31 (MOTS-c + NAD+ + SS-31) appears in 25 author journeys (6 as actual concurrent use). Common goals: CHFrEF and energy support; General health, cellular energy, or anti-aging (popular 14-week protocol); General peptide protocol discussion regarding dosing efficiency.. Typical doses reported: NAD+ 100mg, SS-31 4mg, MOTS-c 5mg. Reported side effects include: None
Typical doses reported
Community-reported doses are not medical guidance.
How people are running it
12
Planning to run
7
Recommended / discussed
3
Currently running
3
Ran in the past
What people use it for
Sample reported outcomes
- ✓ None
- ✓ Still hitting personal records (PRs) regularly with progressive overload.
- ✓ Felt consistently alert throughout the day with no afternoon fatigue
- ✓ Unclear, but noted injection site reactions
- ✓ Experienced bloating and GI discomfort from a single test dose of Betaine Anhydrous
- ✓ synergistic effects
- ✓ Seriously helped with ADD, leading to lowering/titrating off Vyvanse. NAD+ gave off-the-chain energy and focus for the first 4 hours.
- ✓ Not yet started at the time of the post.
Self-reported community experiences, not verified results.
Sample reported side effects
- ⚠ None
- ⚠ Shortness of breath during heavy workouts (compound lift days like legs/back) with MOTS-C; mild injection site pain/sting.
- ⚠ Allergic reaction (itchy face/nose)
- ⚠ Developed subcutaneous non-painful nodules at the injection site (unsure if caused by NAD+ or SS-31)
- ⚠ Bloating and GI discomfort
- ⚠ None reported.
- ⚠ Skin/body tingles from NAD+, burning sensation from MOTS-C injection